Erratum to: Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial

被引:26
|
作者
Ryuji Kaji
Yuka Osako
Kazuaki Suyama
Toshio Maeda
Yasuyuki Uechi
Masaru Iwasaki
机构
[1] Tokushima University Graduate School,Department of Clinical Neuroscience, Institute of Health Biosciences
[2] GlaxoSmithKline K.K.,Japan Development and Medical Affairs Division
关键词
D O I
10.1007/s00415-010-5607-3
中图分类号
学科分类号
摘要
引用
收藏
页码:1416 / 1416
相关论文
共 50 条
  • [1] Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
    Ryuji Kaji
    Yuka Osako
    Kazuaki Suyama
    Toshio Maeda
    Yasuyuki Uechi
    Masaru Iwasaki
    [J]. Journal of Neurology, 2010, 257 : 1330 - 1337
  • [2] Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
    Kaji, Ryuji
    Osako, Yuka
    Suyama, Kazuaki
    Maeda, Toshio
    Uechi, Yasuyuki
    Iwasaki, Masaru
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 (08) : 1330 - 1337
  • [3] A multicenter, double blind, placebo controlled dose response trial of botulinum toxin type a (Botox®) in upper limb spasticity post-stroke
    Childers, MK
    Brashear, A
    Jozefczyk, PB
    Reding, MJ
    Dru, RM
    Lee, CH
    Joshi, TG
    Turkel, CC
    Jenkins, SW
    [J]. NEUROLOGY, 1999, 52 (06) : A295 - A295
  • [4] Botulinum toxin type B in upper-limb poststroke spasticity: A double-blind, placebo-controlled trial
    Brashear, A
    McAfee, AL
    Kuhn, ER
    Fyffe, J
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2004, 85 (05): : 705 - 709
  • [5] Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study
    Gupta, Anupam Datta
    Visvanathan, Renuka
    Cameron, Ian
    Koblar, Simon A.
    Howell, Stuart
    Wilson, David
    [J]. BMC NEUROLOGY, 2019, 19 (1)
  • [6] Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study
    Anupam Datta Gupta
    Renuka Visvanathan
    Ian Cameron
    Simon A. Koblar
    Stuart Howell
    David Wilson
    [J]. BMC Neurology, 19
  • [7] Investigation into the effect of botulinum toxin type A (BoNTA) on walking speed in post-stroke patients: A double-blind, placebo-controlled trial
    Napier-Flood, Fiona
    Olver, John
    Rogers, John D.
    Deane, Jane
    [J]. NEUROLOGY, 2007, 68 (12) : A156 - A157
  • [8] A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury
    Smith, SJ
    Ellis, E
    White, S
    Moore, AP
    [J]. CLINICAL REHABILITATION, 2000, 14 (01) : 5 - 13
  • [9] A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke
    Bakheit, AMO
    Pittock, S
    Moore, AP
    Wurker, M
    Otto, S
    Erbguth, F
    Coxon, L
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) : 559 - 565
  • [10] Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
    Simpson, DM
    Alexander, DN
    OBrien, CF
    Tagliati, M
    Aswad, AS
    Leon, JM
    Gibson, J
    Mordaunt, JM
    Monaghan, EP
    [J]. NEUROLOGY, 1996, 46 (05) : 1306 - 1310